Non-small cell lung cancer cells and concomitant cancer therapy induce a resistance-promoting phenotype of tumor-associated mesenchymal stem cells

MLA

Hanna Sentek, et al. “Non-Small Cell Lung Cancer Cells and Concomitant Cancer Therapy Induce a Resistance-Promoting Phenotype of Tumor-Associated Mesenchymal Stem Cells.” Frontiers in Oncology, vol. 14, July 2024. EBSCOhost, https://doi.org/10.3389/fonc.2024.1406268.

APA

Hanna Sentek, Annika Braun, Bettina Budeus, & Diana Klein. (2024). Non-small cell lung cancer cells and concomitant cancer therapy induce a resistance-promoting phenotype of tumor-associated mesenchymal stem cells. Frontiers in Oncology, 14. https://doi.org/10.3389/fonc.2024.1406268

Chicago

Hanna Sentek, Annika Braun, Bettina Budeus, and Diana Klein. 2024. “Non-Small Cell Lung Cancer Cells and Concomitant Cancer Therapy Induce a Resistance-Promoting Phenotype of Tumor-Associated Mesenchymal Stem Cells.” Frontiers in Oncology 14 (July). doi:10.3389/fonc.2024.1406268.